Defendants claimed herbal products alleviated symptoms of opiate withdrawal and helped users overcome opiate dependency
A company that marketed itself as “the leader in home opiate detox since 2009” and its CEO have settled Federal Trade Commission charges that the withdrawal treatment claims for their “Withdrawal Ease” and “Recovery Ease” products were false or unsupported by scientific evidence

See the full post at FTC.gov